Adrenergic Beta Antagonists
Mostrando 1-12 de 81 artigos, teses e dissertações.
-
1. Role of adenylyl cyclase in reduced β-adrenoceptor-mediated vasorelaxation during maturation
Beta-adrenergic receptor (βAR)-dependent blood vessel relaxation is impaired in older animals and G protein activation has been suggested as the causative mechanism. Here, we investigated the role of βAR subtypes (β1AR, β2AR, and β3AR) and cAMP in maturation-dependent vasorelaxation impairment. Aortic rings from 15 Sprague-Dawley male rats (3 or 9 weeks
Braz J Med Biol Res. Publicado em: 04/07/2016
-
2. Avaliação dos efeitos do betabloqueador nebivolol sobre o peritônio em modelo experimental murino de diálise peritoneal / Assessment of the effects of beta-blocker nebivolol on the peritoneum in an experimental murine model of peritoneal dialysis
A falência de ultrafiltração (UFF) é uma causa importante de interrupção da diálise peritoneal (DP) enquanto terapia renal substitutiva. Além da inflamação crônica e aguda causadas à membrana peritoneal (MP) pelos produtos de degradação da glicose, produtos avançados da glicosilação, pH ácido das soluções e infecções, -bloqueadores (BB)
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 20/10/2011
-
3. Efeitos da associação entre treinamento físico e tratamento farmacológico com -bloqueadores sobre a cardiomiopatia induzida por hiperatividade simpática em camundongos / Effects of the association between exercise training and - blockers in a genetic model of sympathetic hyperactivity induced heart failure in mice
Adicionalmente às alterações estruturais e funcionais observadas na insuficiência cardíaca (IC), as alterações na dinâmica do Ca2+ intracelular apresentam uma relação negativa com a contratilidade e função cardíaca. Para evitar a progressão da IC, o tratamento desta síndrome, conta atualmente com intervenções multifatoriais, incluindo a tera
Publicado em: 2009
-
4. O papel do betabloqueador na miocardiopatia chagásica experimental: avaliação morfo-funcional / The role of betablockade on experimental chagasic cardiomyopathy: morpho-functional evaluation
A doença de Chagas, descrita há quase 100 anos por Carlos Chagas, continua sendo um problema de saúde pública na América Latina, com 15 milhões de infectados e 28 milhões de indivíduos susceptíveis. Vários mecanismos fisiopatológicos foram propostos para a progressão da miocardiopatia chagásica crônica, entre eles a denervação simpática. O u
Publicado em: 2008
-
5. Efeito do tratamento com benazepril e carvedilol administrado de forma isolada e em associação com treinamento físico supervisionado sobre a evolução clínica de cães com insuficiência mitral crônica naturalmente adquirida / Effect of benazepril and carvedilol treatment alone and in association with a supervised physical training in the development of naturally acquired chronic mitral valve regurgitation in dogs
INTRODUCTION: Sympathetic activation is present in patients having chronic mitral valve regurgitation even in asymptomatic ones. However, the effect of beta- blockers and a physical training program to modulate this sympathetic activation during this valve disease is unknown. The objective of this study has been to evaluate the effect of carvedilol and a phy
Publicado em: 2007
-
6. Efeito da terapia com Beta-bloqueadores em camundongos com deleção dos receptores alpha 2A/alpha 2C adrenérgicos / Effects of b- adrenergic antagonist therapy in mice lacking a 2A/a 2C adrenergic receptors
We have recently reported that disruption for both a2A ?and a2C adrenergic receptor subtypes in mice (KO) leads to sympathetic hyperactivity with evidence of heart failure (HF) by the age of 7 months. These mice provide a model system for evaluating the efficiency among different ?- adrenergic antagonists (BB) for HF therapy. In the present study, we evaluat
Publicado em: 2006
-
7. "Procedimentos odontológicos em pacientes hipertensos com ou sem o uso de anestésico local prilocaína associada ou não ao vasoconstritor felipressina" / Dental procedures in hypertensive patients with or without the use of the local anesthetic prilocaine associated or not to the vasoconstrictor felypressin
The objective of this study was to investigate the behavior of blood pressure and the role of anxiety during dental treatment of hypertensive patients. An evaluation was made of sixty-five hypertensive patients (blood pressure = 140/90 mm Hg) under anti-hypertensive treatment were evaluated by the IDATE anxiety test (n = 34), blood pressure measurements 2/2
Publicado em: 2006
-
8. Sensibilidade a agonistas [beta]-adrenergicos em atrio esquerdo isolado de ratos submetidos a estresse
Following foot shock stress white adipocytes and right atria from male and right atria from female rats sacrificed at diestrous, are supersensitive to the chronotropic effect of isoprenaline. Right atria from female rats are also subsensitive to noradrenaline. In the present study, we investigated whether the inotropic response to B-adrenergic agonists was a
Publicado em: 2002
-
9. Structural basis of beta-adrenergic receptor subtype specificity studied with chimeric beta 1/beta 2-adrenergic receptors.
The beta 1- and beta 2-adrenergic receptors are two structurally related, but pharmacologically distinguishable, receptor subtypes, both of which activate adenylyl cyclase in a catecholamine-dependent manner through the guanine nucleotide-binding regulatory protein Gs. The receptors are approximately 50% identical in amino acid sequence and each is character
-
10. Identification of cardiac beta-adrenergic receptors by (minus) [3H]alprenolol binding.
(Minus) [3-H] alprenolol, a potent beta-adrenergic antagonist, was used to identify binding sites in a fraction of canine cyocardium. Beta adrenergic agonists and antagonists compete for these binding sites in a manner which directly parallels their known affinity for the cardiac beta-adrenergic receptor. Thus, binding was highly stereo-specific, with the (m
-
11. Catecholamine binding to the beta-adrenergic receptor.
The adenylate cyclase-coupled beta-adrenergic receptors of frog erythrocyte membranes have been identified by direct radioligand binding techniques using the potent catecholamine agonist (+/-)[3H]hydroxybenzylisproterenol (2-[3, 4-dihydroxyphenyl]-2-hydroxy-1', 1'-dimethyl-2'-[4-hydroxyphenyl]-diethylamine). The successful experimental conditions included th
-
12. Pharmacodynamic Studies of Beta Adrenergic Antagonism Induced in Man by Propranolol and Practolol
The pharmacodynamic activities of two beta adrenergic antagonists, propranolol and practolol, were compared in eight hypertensive patients. The activity of each antagonist was established in relation to its blood concentration at maximal and submaximal adrenergic blockade defined by inhibition of exercise tachycardia. Maximal inhibition of exercise tachycard